Analysis of application of oral hypoglycemic drugs in outpatient department of internal medicine in our hospital from 2014 to 2016

Abstract

Objective To analyze the application status and development tendency of oral hypoglycemic drugs for outpatients in internal medicine of our hospital from 2014 to 2016. Methods By retrospective analysis, the utilization of oral hypoglycemic drugs for outpatients in internal medicine of our hospital from 2014 to 2016 was collected and analyzed statistically in respect of consumption amount, consumption sum, defined daily dose system (DDDs), and daily drug cost (DDC). Results The consumption sum of oral hypoglycemic drugs for outpatients in internal medicine of our hospital showed an increase tendency overall. Repaglinide, metformin, and acarbose ranked the first three places in consumption sum. The use frequency of metformin continuously dominated the first place during the last three years. Repaglinide and acarbose had higher DDC, while gliclazide and glipizide had lower DDC. Conclusion The application of oral hypoglycemic drugs for outpatients in internal medicine of our hospital is basically rational from 2014 to 2016. Key words: Oral hypoglycemic drugs; Consumption sum; DDDs; DDC